Home
>
National Drug Code (NDC)
>
MiraLAX
MiraLAX - 11523-7234-1 - (Polyethylene Glycol 3350)
Drug Information of MiraLAX
| Product NDC: | 11523-7234 |
| Proprietary Name: | MiraLAX |
| Non Proprietary Name: | Polyethylene Glycol 3350 |
| Active Ingredient(s): | 17 g/17g & nbsp; Polyethylene Glycol 3350 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MiraLAX
| Product NDC: | 11523-7234 |
| Labeler Name: | MSD Consumer Care, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA022015 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090223 |
Package Information of MiraLAX
| Package NDC: | 11523-7234-1 |
| Package Description: | 17 g in 1 PACKET (11523-7234-1) |
NDC Information of MiraLAX
| NDC Code | 11523-7234-1 |
| Proprietary Name | MiraLAX |
| Package Description | 17 g in 1 PACKET (11523-7234-1) |
| Product NDC | 11523-7234 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Polyethylene Glycol 3350 |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20090223 |
| Marketing Category Name | NDA |
| Labeler Name | MSD Consumer Care, Inc. |
| Substance Name | POLYETHYLENE GLYCOL 3350 |
| Strength Number | 17 |
| Strength Unit | g/17g |
| Pharmaceutical Classes |
